Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Pasithea Therapeutics (KTTA) Long-Term Debt Issuances (2021 - 2023)

Pasithea Therapeutics (KTTA) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $392354.0 as the latest value for Q1 2023.

  • Quarterly Long-Term Debt Issuances changed N/A to $392354.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $392354.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $392354.0 for FY2023, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $392354.0 in Q1 2023 for Pasithea Therapeutics, down from $5.3 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $20.7 million in Q3 2021 to a low of $392354.0 in Q1 2023.